Literature DB >> 22777418

Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.

Rob H P Hilgers1, Dongqi Xing, Kaizheng Gong, Yiu-Fai Chen, John C Chatham, Suzanne Oparil.   

Abstract

Acute increases in cellular protein O-linked N-acetyl-glucosamine (O-GlcNAc) modification (O-GlcNAcylation) have been shown to have protective effects in the heart and vasculature. We hypothesized that d-glucosamine (d-GlcN) and Thiamet-G, two agents that increase protein O-GlcNAcylation via different mechanisms, inhibit TNF-α-induced oxidative stress and vascular dysfunction by suppressing inducible nitric oxide (NO) synthase (iNOS) expression. Rat aortic rings were incubated for 3h at 37°C with d-GlcN or its osmotic control l-glucose (l-Glc) or with Thiamet-G or its vehicle control (H(2)O) followed by the addition of TNF-α or vehicle (H(2)O) for 21 h. After incubation, rings were mounted in a myograph to assess arterial reactivity. Twenty-four hours of incubation of aortic rings with TNF-α resulted in 1) a hypocontractility to 60 mM K(+) solution and phenylephrine, 2) blunted endothelium-dependent relaxation responses to ACh and substance P, and 3) unaltered relaxing response to the Ca(2+) ionophore A-23187 and the NO donor sodium nitroprusside compared with aortic rings cultured in the absence of TNF-α. d-GlcN and Thiamet-G pretreatment suppressed the TNF-α-induced hypocontractility and endothelial dysfunction. Total protein O-GlcNAc levels were significantly higher in aortic segments treated with d-GlcN or Thiamet-G compared with controls. Expression of iNOS protein was increased in TNF-α-treated rings, and this was attenuated by pretreatment with either d-GlcN or Thiamet-G. Dense immunostaining for nitrotyrosylated proteins was detected in the endothelium and media of the aortic wall, suggesting enhanced peroxynitrite production by iNOS. These findings demonstrate that acute increases in protein O-GlcNAcylation prevent TNF-α-induced vascular dysfunction, at least in part, via suppression of iNOS expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777418      PMCID: PMC3468474          DOI: 10.1152/ajpheart.01175.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  53 in total

1.  Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.

Authors:  Norbert Fülöp; Zhenghao Zhang; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-05       Impact factor: 4.733

2.  Glucosamine administration during resuscitation improves organ function after trauma hemorrhage.

Authors:  Shaolong Yang; Lu-Yun Zou; Pam Bounelis; Irshad Chaudry; John C Chatham; Richard B Marchase
Journal:  Shock       Date:  2006-06       Impact factor: 3.454

3.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

Authors:  Scott A Yuzwa; Matthew S Macauley; Julia E Heinonen; Xiaoyang Shan; Rebecca J Dennis; Yuan He; Garrett E Whitworth; Keith A Stubbs; Ernest J McEachern; Gideon J Davies; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2008-06-29       Impact factor: 15.040

4.  Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro.

Authors:  Jiann-Torng Chen; Po-Liang Chen; Yun-Hsiang Chang; Ming-Wei Chien; Yi-Hao Chen; Da-Wen Lu
Journal:  Exp Eye Res       Date:  2006-07-05       Impact factor: 3.467

5.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

6.  Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22(Phox) and iNOS expression.

Authors:  C Valvason; E Musacchio; A Pozzuoli; R Ramonda; R Aldegheri; L Punzi
Journal:  Rheumatology (Oxford)       Date:  2008-01       Impact factor: 7.580

7.  Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.

Authors:  Masao Takahashi; Etsu Suzuki; Ryo Takeda; Shigeyoshi Oba; Hiroaki Nishimatsu; Kenjiro Kimura; Tetsuo Nagano; Ryozo Nagai; Yasunobu Hirata
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

Review 8.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

Authors:  Gerald W Hart; Michael P Housley; Chad Slawson
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

Review 9.  Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.

Authors:  John C Chatham; Laszlo G Nöt; Norbert Fülöp; Richard B Marchase
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

10.  Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB.

Authors:  Mohamed M Rafi; Prem N Yadav; Andrea O Rossi
Journal:  Mol Nutr Food Res       Date:  2007-05       Impact factor: 5.914

View more
  37 in total

1.  O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

Authors:  Rodrigo Pacheco Silva-Aguiar; Nathália C F Bezerra; Miguel C Lucena; Gabriela M Sirtoli; Roberto T Sudo; Gisele Zapata-Sudo; Christina M Takiya; Ana Acacia S Pinheiro; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

Review 2.  Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Authors:  Susan A Marsh; Helen E Collins; John C Chatham
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

3.  High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?

Authors:  Victor V Lima; Fernanda R Giachini; Takayuki Matsumoto; Weiguo Li; Alecsander F M Bressan; Dhruv Chawla; R Clinton Webb; Adviye Ergul; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2016-02-29       Impact factor: 6.124

Review 4.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

5.  Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin.

Authors:  Chunyan Hu; Henry L Keen; Ko-Ting Lu; Xuebo Liu; Jing Wu; Deborah R Davis; Stella-Rita C Ibeawuchi; Silke Vogel; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2017-03-23

Review 6.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

8.  Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.

Authors:  Jack M Heath; Yong Sun; Kaiyu Yuan; Wayne E Bradley; Silvio Litovsky; Louis J Dell'Italia; John C Chatham; Hui Wu; Yabing Chen
Journal:  Circ Res       Date:  2014-02-13       Impact factor: 17.367

9.  O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes.

Authors:  Ayşe Karababa; Boris Görg; Freimut Schliess; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2013-12-01       Impact factor: 3.584

10.  O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.

Authors:  Ayako Makino; Anzhi Dai; Ying Han; Katia D Youssef; Weihua Wang; Reshma Donthamsetty; Brian T Scott; Hong Wang; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-12       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.